Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06547385 2024-08-09

Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer

Phase 1 Active not recruiting

40 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00107250 2023-08-04

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Phase 1 Completed

50 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00291486 2022-10-10

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

Phase 1 Completed

19 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms

NCT01705002 2018-07-10

Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.

Phase 1 Completed

88 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT00536809 2017-12-18

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

Phase 1 Completed

12 enrolled 6 charts

Gastrointestinal

Colorectal Neoplasms

NCT02210364 2016-12-14

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

Phase 1 Completed

81 enrolled

BreastGastrointestinal

Breast Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01493336 2016-11-02

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

Phase 1 Completed

37 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT02720926 2016-03-28

Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer

Phase 1 Terminated

3 enrolled

Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT00353262 2016-03-04

A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

Phase 1 Completed

36 enrolled 18 charts

Gastrointestinal

Colorectal Neoplasms

NCT00019773 2015-04-29

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Phase 1 Completed

Gastrointestinal

Appendiceal Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01157052 2014-10-01

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Phase 1 Unknown

15 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00183833 2014-05-22

Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01306630 2014-01-27

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Phase 1 Completed

24 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01846650 2013-10-01

A Bioequivalence Study of Capecitabine Tablets

Phase 1 Completed

36 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT00296062 2012-01-16

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Phase 1 Terminated

12 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00084591 2010-02-12

Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer

Phase 1 Completed

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms